ELI LILLY AND COMPAN

LLY

Delayed - 11/25 03:55:31 pm
144.59USD	-0.21%

Prev.	144.9000
Open	144.9000
High	145.3400
Low	142.6100
Volume	2 036 066

6h ago	Eli Lilly and Company : - Lilly to Participate in Evercore ISI 3rd Annual...
1d ago	Eli Lilly and : Lilly to Participate in Evercore ISI 3rd Annual HealthCONx...
1d ago	Eli Lilly and : to Supply Bamlanivimab to Treat Covid-19 in Canada
1d ago	UPS Preparing to Help Ship, Store Covid-19 Vaccines

	Short Term	Mid-Term	Long Term
Trend	Bullish	Neutral	Neutral
Resistance	149	169	166
Spread/Res.	-2,6%	-14%	-13%
Spread/Supp.	3,6%	11%	18%
Support	140	130	122

Sales 2020	23 681 M - -
Net income 2020	6 011 M - -
Net Debt 2020	11 184 M - -
P/E ratio 2020	22,7x
Yield 2020	2,04%

Capitalization	131 B 131 B -
EV / Sales 2020	6,02x
EV / Sales 2021	5,39x
Nbr of Employees	33 625
Free-Float	99,8%

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or...

>> Read more

Sector :

Pharmaceuticals - NEC

Calendar :

2020-12-15 Guidance Call

Trading Rating :

Investor Rating :

Mean consensus	OUTPERFORM
Number of Analysts	20
Average target price	164,58 $
Last Close Price	144,90 $
Spread / Highest target	38,0%
Spread / Average Target	13,6%
Spread / Lowest Target	-17,2%